Editorials on STING for cancer immunotherapy

I recently published two Editorials on the use of STING agonists for cancer immunotherapy, you will find them here:

Berger, Lawler – 2018 – Novel non-nucleotidic STING agonists for cancer immunotherapy

Marloye, Lawler, Berger – 2019 – Current patent and clinical status of stimulator of interferon genes (STING) agonists for cancer immunotherapy

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s